Research team
Expertise
The validation of theranostic radiopharmaceuticals for using various preclinical disease models. Developing radiotracers for non-invasive and longitudinal whole-body diagnosis of disease and monitoring of therapeutic responses using SPECT and PET imaging. Evaluation of therapeutic efficacy of radiopharmaceuticals in preclinical oncological models.